JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB231511

Dolutegravir, HIV integrase inhibitor

Be the first to review this product! Submit a review

|

(1 Publication)

MW 419.4 Da. Potent HIV integrase inhibitor (IC50 = 2.7 nM for HIV-1 integrase-catalyzed strand transfer in vitro). Inhibits HIV-1 viral replication (EC50 = 0.51 nM) in peripheral blood mononuclear cells (PBMCs). Prevents replication of several HIV-1 strains (EC50 values of 0.36-2.1 nM) that are resistant to nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors.

View Alternative Names

1,8-cineole 2-exo-monooxygenase, AChR, AL024364, Aging-associated gene 8 protein, Albendazole monooxygenase, Albendazole sulfoxidase, BILIQTL1, Bilirubin-specific UDPGT isozyme 1, CP33, CP34, CP3A4_HUMAN, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIIA3, CYPIIIA4, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450-PCN1, EC 2.4.1.17, GNT1, Glucocorticoid inducible P450, HLP, HUG-BR1, MGC126680, MGC12716, NF 25, Nifedipine oxidase, P450 III steroid inducible, P450 PCN1, P450, family III, P450C3, PHENOL/BILIRUBIN UDP GLUCURONOSYLTRANSFERASE, Quinine 3-monooxygenase, RP23 167I12.6, SGMR1_HUMAN, SIG-1R, SR-BP, SR31747-binding protein, Sigma 1-type opioid receptor, Sigma non-opioid intracellular receptor 1, Sigma1-receptor, Sigma1R, Sigmar1, Slc18a3, Solute carrier family 18 (vesicular acetylcholine) member 3, Solute carrier family 18 (vesicular monoamine) member 3, Solute carrier family 18 member 3, Taurochenodeoxycholate 6-alpha-hydroxylase, UD11_HUMAN, UDP GLYCOSYLTRANSFERASE 1, UDP glucuronosyltransferase 1 1 [Precursor], UDP glucuronosyltransferase 1 family polypeptide A1, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-A, UDP-glucuronosyltransferase 1A1, UDPGT, UDPGT 1-1, UGT-1A, UGT1, UGT1*1, UGT1-01, UGT1.1, URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL, URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1, URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1, VACHT_HUMAN, Vesicular acetylcholine transporter, bilirubin UDP glucuronosyltransferase 1 1, bilirubin UDP glucuronosyltransferase isozyme 1, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, hSigmaR1, mSigmaR1, opioid receptor, sigma 1, opioid receptor, sigma 1 isoform 1, rVAT

1 Images
Chemical Structure - Dolutegravir, HIV integrase inhibitor (AB231511)
  • Chemical Structure

Lab

Chemical Structure - Dolutegravir, HIV integrase inhibitor (AB231511)

2D chemical structure image of ab231511, Dolutegravir, HIV integrase inhibitor

Key facts

CAS number

1051375-16-6

Form

Solid

form

Molecular weight

419.4 Da

Molecular formula

C<sub>2</sub><sub>0</sub>H<sub>1</sub><sub>9</sub>F<sub>2</sub>N<sub>3</sub>O<sub>5</sub>

PubChem

54726191

Nature

Synthetic

Solubility

Soluble in DMSO to 5mM.

Biochemical name

Dolutegravir

Biological description

Potent HIV integrase inhibitor (IC50 = 2.7 nM for HIV-1 integrase-catalyzed strand transfer in vitro). Inhibits HIV-1 viral replication (EC50 = 0.51 nM) in peripheral blood mononuclear cells (PBMCs). Prevents replication of several HIV-1 strains (EC50 values of 0.36-2.1 nM) that are resistant to nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors.

Canonical smiles

CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O

Isomeric smiles

C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O

InChi

InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1

InChiKey

RHWKPHLQXYSBKR-BMIGLBTASA-N

IUPAC Name

(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytochrome P450 3A4 also known as CYP3A4 is a member of the cytochrome P450 family of enzymes. It is a versatile monooxygenase with a mass of about 57 kDa. One can find CYP3A4 abundantly expressed in the liver and intestinal mucosa playing a critical role in metabolizing a wide range of xenobiotics and endogenous compounds. Vesicular acetylcholine transporter (VAChT) a membrane protein responsible for transporting acetylcholine into synaptic vesicles and Sigma1-receptor a chaperone protein located in the endoplasmic reticulum are two key players within the cellular environment. UDP-glucuronosyltransferase 1A1 (UGT1A1) is primarily involved in the glucuronidation process contributing significantly to the detoxification and metabolization pathways.
Biological function summary

CYP3A4 is important in metabolizing nearly 50% of all drugs including integrase inhibitors like dolutegravir used in HIV therapy. This enzyme mediates the oxidative metabolism impacting drug absorption and clearance rates. VAChT facilitates synaptic transmission by packaging acetylcholine while Sigma1-receptor is involved in cell signaling and stress response modulation. UGT1A1 is essential in bilirubin clearance and metabolizing various xenobiotics and endogenous substances. These targets are not part of a singular complex but exhibit essential roles individually within their respective pathways.

Pathways

These proteins perform integral roles in different biological functions. CYP3A4 is central in the drug metabolism pathway alongside other CYPs influencing the pharmacokinetics of many medications. VAChT is involved in cholinergic neurotransmission critical for nerve signal propagation. Similarly Sigma1-receptor is part of the neuroprotective and apoptotic pathways related to calcium signaling and lipid transport. UGT1A1 is prominently featured in the glucuronidation pathway a phase II drug metabolism process closely linked with heme and bilirubin metabolism. These proteins have specific yet interconnected pathways functioning with various related proteins.

CYP3A4's activity significantly affects treatment outcomes in patients with HIV given its role in metabolizing most antiretroviral drugs including dolutegravir - an integrase inhibitor. Variations in CYP3A4 activity can lead to alterations in drug efficacy and toxicity intersecting with proteins involved in hepatic metabolism. VAChT dysfunction is associated with neurological disorders such as Alzheimer's disease impacting neurotransmitter regulation. Sigma1-receptor is implicated in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) due to its role in neuroprotection while UGT1A1 is directly involved in conditions like Gilbert's syndrome affecting bilirubin conjugation. These proteins contribute to disease mechanisms highlighting their importance in therapeutic contexts.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

The Journal of biological chemistry 295:13023-13030 PubMed32719008

2020

Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag.

Applications

Unspecified application

Species

Unspecified reactive species

Seiya Ozono,Yanzhao Zhang,Minoru Tobiume,Satoshi Kishigami,Kenzo Tokunaga
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com